首页 | 本学科首页   官方微博 | 高级检索  
检索        

中医药治疗原发性非小细胞肺癌疗效的Meta分析
引用本文:陈志峰,李成柱.中医药治疗原发性非小细胞肺癌疗效的Meta分析[J].中医杂志,1999,40(5):287-289.
作者姓名:陈志峰  李成柱
作者单位:[1]河北省肿瘤研究所 [2]河北省医学科学院附属医院
摘    要:应用Meta分析方法(MA)的随机效应模型,对国内7年来单纯采用中医药治疗原发性非小细胞肺癌(NSCL)并以化疗作对照的研究文献进行定量合并分析,MA结果显示,中医药组稳定率OR=2,10,95%CI(0.70~3.08)资料齐性检验Q=24.24,V=12,P〉0.01;化疗组有效率OR=1.48,95%CI(1.03~2.24),Q=2.89,V=8,P〉0.05。统计7篇文章中位生存期,中医

关 键 词:肺肿瘤  中医药疗法  Meta分析  非小细胞肺癌

Meta Analysis on Primary Non- small Cell Lung Carcinoma (NSCL) Treated by TCM in China
Chen Zhifeng,Li Chengzhu,Liu Shaoxiang et al.Meta Analysis on Primary Non- small Cell Lung Carcinoma (NSCL) Treated by TCM in China[J].Journal of Traditional Chinese Medicine,1999,40(5):287-289.
Authors:Chen Zhifeng  Li Chengzhu  Liu Shaoxiang
Institution:Chen Zhifeng,Li Chengzhu,Liu Shaoxiang et al. Institute of Oncology,Shijiazhuang,Hebei 050011
Abstract:Chen Zhifeng, Li Chengzhu, Liu Shaoxiang et al. By applying random - effect model of meta analysis (MA), quantitative analysis was also made on literatures of non - small cell lung - cancer treated with TCM alone in the past 7 years, with that treated by chemotherapy as control. MA results showed that the stability rate of TCM group was OR = 2. 10, 95% CI (0. 70-3. 08), complete data exam Q = 24. 24, V = 12 F>0. 01. In the themotherapeutic group. OR = 1.48, 95% CI (1.03-2. 24), Q = 2. 89, V = 8, P> 0.05. Statistics from 7 papers revealed the mean survival rate of TCM group was 335. 4 days, that of chemotherapeutic group 231. 8, test of significance P = 0. 1489. MA results showed that the features of TCM treatment on NSCL were: high stability, low effectiveness, however, with certain dominance. Authors' address: Institute of Oncology, Shijiazhuang, Hebei 050011
Keywords:Lung cancer/TCM therapy cancer non -small cell/TCM therapy @ Meta analysis  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号